An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANTX | FATE | VTVT | ||
| Company | An2 Therapeutics Inc | Fate Therapeutics | Vtv Theraptcs Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.88 | 1.2300 | 36.32 | ||
| High | 5.39 | 1.2600 | 37.58 | ||
| Low | 4.71 | 1.1850 | 32.67 | ||
| Latest | 5.04 | 1.1900 | 33.69 | ||
| Change | -0.05 | -0.0400 | -1.41 | ||
| % Change | -0.98% | -3.25% | -4.02% | ||
| Volume | 341,722 | 342,542 | 84,079 | ||
| 20-Day Average Volume | 3,708,121 | 1,640,180 | 51,610 | ||
| Previous Close | 5.09 | 1.2300 | 35.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.04 | 1.3871 | 36.24 | ||
| 20-Day Raw Stochastic | 71.91% | 8.49% | 22.38% | ||
| 20-Day Relative Strength | 87.85 | 45.49 | 47.72 | ||
| Weighted Alpha | +32.32 | -10.88 | +112.94 | ||
| Today's Opinion | 100% Buy | 64% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 40% Buy | ||
| Last Month's Opinion | 56% Sell | 48% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +207.02% since 03/05/26 | -13.64% since 03/05/26 | -8.25% since 03/05/26 | ||
| Low | 1.57 on 03/06/26 | 1.1900 on 03/12/26 | 32.67 on 03/12/26 | ||
| High | 6.91 on 03/09/26 | 1.3800 on 03/10/26 | 38.44 on 03/11/26 | ||
| 1-Month | |||||
| %Chg | +400.00% since 02/12/26 | -0.69% since 02/12/26 | -6.41% since 02/12/26 | ||
| Low | 1.00 on 02/19/26 | 1.1800 on 02/13/26 | 32.67 on 03/12/26 | ||
| High | 6.91 on 03/09/26 | 1.6950 on 02/25/26 | 41.66 on 02/24/26 | ||
| 3-Month | |||||
| %Chg | +337.50% since 12/12/25 | +3.63% since 12/12/25 | -1.39% since 12/12/25 | ||
| Low | 1.00 on 02/19/26 | 0.9510 on 12/23/25 | 28.84 on 02/06/26 | ||
| High | 6.91 on 03/09/26 | 1.6950 on 02/25/26 | 44.00 on 01/06/26 | ||
| 6-Month | |||||
| %Chg | +310.16% since 09/12/25 | +23.74% since 09/12/25 | +72.82% since 09/12/25 | ||
| Low | 1.00 on 02/19/26 | 0.9401 on 09/15/25 | 18.97 on 09/17/25 | ||
| High | 6.91 on 03/09/26 | 1.9399 on 10/27/25 | 44.00 on 01/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 139,476 | 143,004 | 138,234 | ||
| Shares Outstanding, K | 27,402 | 116,263 | 3,938 | ||
| Annual Sales | 0 | 6,650,000 | 1,020,000 | ||
| Annual Net Income | -51,320,000 | -136,320,000 | -18,460,000 | ||
| Last Quarter Sales | 0 | 1,370,000 | 0 | ||
| Last Quarter Net Income | -9,350,000 | -32,370,000 | -8,700,000 | ||
| 60-Month Beta | -0.02 | 2.19 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 11/12/25 | -0.27 on 11/13/25 | -1.08 on 11/06/25 | ||
| Latest Earnings Date | 03/24/26 | 05/12/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||